From: Fecal carriage of multidrug-resistant Escherichia coli by community children in southern Taiwan
Non-susceptible rate % (number/total number) | ||||
---|---|---|---|---|
Total | MDR E. coli (n = 58) | Non MDR E. coli (n = 99) | p | |
Flormoxef | 7.6 (12/157) | 17.2 (10/58) | 2.0 (2/99) | 0.001 |
Ampicillin | 70.1 (110/157) | 100.0 (58/58) | 52.5 (52/99) | < 0.001 |
Amoxicillin/clavunate | 65.6 (103/157) | 96.6 (56/58) | 47.5 (47/99) | < 0.001 |
Cefazolin | 32.5 (51/157) | 77.6 (45/58) | 6.1 (6/99) | < 0.001 |
Cefuroxime | 22.9 (36/157) | 55.2 (32/58) | 4.0 (4/99) | < 0.001 |
Cefuroxime Axetil | 24.8 (39/157) | 55.2 (32/58) | 7.1 (7/99) | < 0.001 |
Cefoxitin | 15.3 (24/157) | 37.9 (22/58) | 2.0 (2/99) | < 0.001 |
Cefotaxime | 19.6 (31/157) | 46.6 (27/58) | 4.0 (4/99) | < 0.001 |
Ceftazidime | 13.4 (21/157) | 29.3 (17/58) | 4.0 (4/99) | < 0.001 |
Cefpirome | 8.3 (13/157) | 19.0 (11/58) | 2.0 (2/99) | < 0.001 |
Ertapenem | 0.0 (0/157) | 0.0 (0/58) | 0.0 (0/99) | NA |
Imipenem | 0.0 (0/157) | 0.0 (0/58) | 0.0 (0/99) | NA |
Amikin | 0.0 (0/157) | 0.0 (0/58) | 0.0 (0/99) | NA |
Gentamicin | 22.9 (36/157) | 60.3 (35/58) | 1.0 (1/99) | < 0.001 |
Ciprofloxacin | 18.5 (29/157) | 43.1 (25/58) | 4.0 (4/99) | < 0.001 |
Moxifloxacin | 19.1 (30/157) | 43.1 (25/58) | 5.1 (5/99) | < 0.001 |
Tigecycline | 0.0 (0/157) | 0.0 (0/58) | 0.0 (0/99) | NA |
Colistin | 0.6 (1/157) | 1.7 (1/58) | 0.0 (0/99) | 0.190 |
Trimethoprim-sulfamethoxazole | 47.1 (74/157) | 84.5 (49/58) | 25.3 (25/99) | < 0.001 |